title: Ebselen pretreatment attenuates ischemia/reperfusion injury and prevents hyperglycemia by improving hepatic insulin signaling and β-cell survival in gerbils.
abstract: Transient carotid artery occlusion causes ischemia/reperfusion (I/R) injury resulting in neuron and pancreatic β-cell death with consequential post-stroke hyperglycemia, which can lead to diabetes and may accelerate the development of Alzheimer's disease. Antioxidants have been shown to protect against the I/R injury and destruction of neurons. However, it is unknown whether the protection against I/R injury extends to the pancreatic β-cells. Therefore, we investigated whether treatment with ebselen, a glutathione peroxidase mimic, prevents neuronal and β-cell death following I/R in gerbils susceptible to stroke. After 28 days post artery occlusion, there was widespread neuronal cell death in the CA1 of the hippocampus and elevated IL-1β and TNF-α levels. Pretreatment with ebselen prevented the death by 56% and attenuated neurological damage (abnormal eyelid drooping, hair bristling, muscle tone, flexor reflex, posture, and walking patterns). Ischemic gerbils also exhibited impaired glucose tolerance and insulin sensitivity which induced post-stroke hyperglycemia associated with decreased β-cell mass due to increased β-cell apoptosis. Ebselen prevented the increased β-cell apoptosis, possibly by decreasing IL-1β and TNF-α in islets. Ischemia also attenuated hepatic insulin signaling, and expression of GLUT2 and glucokinase, whereas ebselen prevented the attenuation and suppressed gluconeogenesis by decreasing PEPCK expression. In conclusion, antioxidant protection by ebselen attenuated I/R injury of neurons and pancreatic β-cells and prevented subsequent impairment of glucose regulation that could lead to diabetes and Alzheimer's disease.
authors.affiliation: Department of Food and Nutrition, College of Natural Science, Obesity/Diabetes Research Institutes, Hoseo University , Asan-Si , Republic of Korea.
authors.forename: S
authors.initials: S
authors.lastname: Park
authors.forename: S
authors.initials: S
authors.lastname: Kang
authors.forename: D S
authors.initials: DS
authors.lastname: Kim
authors.forename: B K
authors.initials: BK
authors.lastname: Shin
authors.forename: N R
authors.initials: NR
authors.lastname: Moon
authors.forename: J W
authors.initials: JW
authors.lastname: Daily
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001393:Azoles / Q000494:pharmacology*; D002545:Brain Ischemia / Q000188:drug therapy*; D002470:Cell Survival; D016207:Cytokines / Q000378:metabolism; D005849:Gerbillinae; D006003:Glycogen / Q000378:metabolism; D006943:Hyperglycemia / Q000188:drug therapy; D007328:Insulin / Q000378:metabolism* / Q000494:pharmacology; D050417:Insulin-Secreting Cells / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D054833:Isoindoles; D008099:Liver / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D016566:Organoselenium Compounds / Q000494:pharmacology*; D011897:Random Allocation; D015427:Reperfusion Injury / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001393:Azoles; D016207:Cytokines; D007328:Insulin; D054833:Isoindoles; D016566:Organoselenium Compounds; C042986:ebselen; D006003:Glycogen
keywords: ant-oxidant; cerebral ischemia; glucose; insulin; β-cell apoptosis